the frontier of
weight loss
Retatrutide is an investigational triple-agonist targeting three metabolic pathways — the next step beyond today's GLP-1 medications. Physician-supervised, all-inclusive, and closely monitored.
why triple-action matters
Semaglutide works on one pathway. Tirzepatide works on two. Retatrutide is designed to work on three — adding glucagon-receptor activity to GLP-1 and GIP to influence appetite, fullness, and energy expenditure together.
Three pathways, one shot
The first triple-agonist approach — engaging more of your metabolism than single or dual-action options.
Deep appetite control
Combined hormone action targets hunger and fullness on multiple fronts.
Energy expenditure
The glucagon component may support how your body burns energy, not just how much you eat.
Close medical oversight
As a newer therapy, your provider monitors you carefully and titrates your dose with extra care.
| Semaglutide | Tirzepatide | Retatrutide | |
|---|---|---|---|
| Hormone pathways | GLP-1 | GLP-1 + GIP | GLP-1 + GIP + Glucagon |
| Action | Single | Dual | Triple |
| Injection frequency | Weekly | Weekly | Weekly |
| Status | FDA-approved | FDA-approved | Investigational |
| Monthly price | $450/mo | $550/mo | $650 / 6-wk |
Book a consult
Come in for your physician evaluation — no referral needed.
Get your plan
We assess whether retatrutide is right for you and build a dosing plan.
Start weekly
Begin your weekly injections with close provider oversight.
Monitor closely
Regular check-ins to track progress and adjust as needed.
- ✓Full month supply of retatrutide
- ✓Physician evaluation & personalized dosing
- ✓Close monitoring & dose titration
- ✓Free B-12 shot with every visit
- ✓Triple-action GLP-1 + GIP + glucagon
- ✓Nutrition & lifestyle guidance
Is retatrutide FDA-approved?
Not yet — retatrutide is still investigational and under clinical study, unlike semaglutide and tirzepatide, which are FDA-approved. Your provider will discuss what this means for you and whether it's an appropriate option during your consultation.
How is it different from tirzepatide?
Tirzepatide acts on two hormone pathways (GLP-1 + GIP). Retatrutide is designed to act on three, adding glucagon-receptor activity. Your provider can explain how that may affect your results.
Is the medication included in the $650?
Yes — medication, provider visits, and check-ins are all covered. No separate pharmacy bill, no hidden fees.
Are there side effects?
As with other GLP-1 therapies, the most common are mild and temporary — nausea, reduced appetite, or digestive changes. Because this is a newer therapy, your provider monitors you especially closely.
Can I switch or cancel?
Yes — it's month-to-month with no contracts, and you can discuss switching programs with your provider anytime.
curious if it's right for you?
Book a physician consultation to discuss retatrutide and find the weight-loss program that fits your goals.